Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer

Gynecologic Oncology

Volumn 111, Issue 2, 2008, Pages 356-364

  Jonson, Amy L ^a,b   Rogers, Lisa M ^a,b   Ramakrishnan, Sundaram ^a,b   Downs Jr , Levi S ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cervical cancer; E6; E7; HPV; siRNA

Indexed keywords

LAMIN; MESSENGER RNA; PROTEIN E6; PROTEIN E7; PROTEIN P53; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA SEQUENCE; TUMOR VOLUME; UTERINE CERVIX CANCER; VIRUS ONCOGENE;

ANIMALS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; GENE SILENCING; GENE THERAPY; MICE; MICE, NUDE; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 55649097304     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.06.033     Document Type: Article

References (26)

1. Franco E.L., Schlecht N.F., and Saslow D. The epidemiology of cervical cancer. Cancer 9 5 (2003) 348-359
2. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 1 (1999) 12-19
3. Mantovani F., and Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20 54 (2001) 7874-7887
4. Schniffner M., and Whitaker N.J. Human papillomavirus induced carcinogenesis and the ubiquitin-proteasome system. Semin. Cancer Biol. 13 1 (2003) 59-67
5. Bequet-Romero M., and Lopez-Ocejo O. Angiogenesis modulators expression in culture cell lines positives for HPV-16 oncoproteins. Biochem. Biophys. Res. Commun. 277 1 (2000) 55-61
6. Lopez-Ocejo O., Viloria-Petit A., Bequet-Romero M., Mukhopadhyay D., Rak J., and Kerbel R.S. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. Oncogene 19 (2000) 4611-4620
7. Toussaint-Smith E., Donner D.B., and Roman A. Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors. Oncogene 23 (2004) 2988-2995
8. Butz K., Ristriani T., Hengstermann A., Denk C., Scheffner M., and Hoppe-Seyler F. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene 22 38 (2003) 5938-5945
9. Hall A.H., and Alexander K.A. RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells. J. Virol. 77 10 (2003) 6066-6069
10. Jiang M., and Milner J. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 21 39 (2002) 6041-6048
11. Yamato K., Fen J., Kobuchi H., Nasu Y., Yamada T., Nishihara T., et al. Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA. Cancer Gene Ther. (2005)
12. Yoshinouchi M., Yamada T., Kizaki M., Fen J., Koseki T., Ikeda Y., et al. In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA. Mol. Ther. 8 5 (2003) 762-768
13. Kuroda M., Kiyono T., Oikawa K., Yoshida K., and Mukai K. The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target. Br. J. Cancer 92 2 (2005) 290-293
14. Campochiaro P.A. Potential applications for RNAi to prove pathogenesis and develop new treatments for ocular disorders. Gene Therapy 13 (2006) 559-562
15. Landen Jr. C.N., Chavez-Reyes A., Bucana C., Schmandt R., Deavers M.T., Lopez-Berestein G., et al. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res. 65 15 (2005) 6910-6918
16. Takei Y., Kadomatsu K., Yuzawa Y., Matsuo S., and Muramatsu T. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res. 64 10 (2004) 3365-3370
17. Urban-Klein B., Werth S., Abuharbeid S., Czubayko F., and Aigner A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther. 12 5 (2005) 461-466
18. Kleinman M.E., Yamada K., Takeda A., Chandrasekaran V., Nozaki M., Baffi J.Z., et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452 7187 (2008) 591-597
19. Koivusalo R., Krausz E., Helenius H., and Hietanen S. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs. Mol. Pharmacol. 68 2 (2005) 372-382
20. Niu X.Y., Peng Z.L., Duan W.Q., Wang H., and Wang P. Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo. Int. J. Gynecol. Cancer 16 (2006) 743-751
21. Gu W., Putral L., Hengst K., Minto K., Saunders N.A., Leggatt G., et al. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes. Cancer Gene Ther. 13 (2006) 1023-1032
22. Fuji T., Saito M., Iwaski E., Ochiya T., Takei Y., Hayashi S., et al. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer. Int. J. Oncol. 29 3 (2006) 541-548
23. Leung R.K., and Whittaker P.A. RNA interference: from gene silencing to gene-specific therapeutics. Pharmacol. Ther. 107 2 (2005) 222-239 Review
24. Soutschek J., Akinc A., Bramlage B., Charisse K., Constien R., Donoghue M., et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432 7014 (2004) 173-178
25. Kim D.H., Longo M., Han Y., Lundberg P., Cantin E., and Rossi J.J. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat. Biotechnol. 22 3 (2004) 321-325
26. Sledz C.A., Holko M., de Veer M.J., Silverman R.H., and Williams B.R. Activation of the interferon system by short-interfering RNAs. Nat. Cell. Biol. 5 9 (2003) 834-839